Literature DB >> 32162171

CircMACF1 Attenuates Acute Myocardial Infarction Through miR-500b-5p-EMP1 Axis.

Bo Zhao1, Guangping Li2,3, Jianjun Peng1, Lihui Ren1, Licheng Lei1, Huiming Ye1, Zuoyan Wang1, Sheng Zhao1.   

Abstract

It is widely accepted that circular RNA (circRNA) plays an important role in cardiovascular diseases. Therefore, this experiment aimed to investigate the pathogenesis of circMACF1 in acute myocardial infarction (AMI). qRT-PCR and immunoblotting were used to detect the expression levels of circMACF1, miR-500b-5p, and epithelial membrane protein 1 (EMP1). The role of circMACF1, miR-500b-5p, and EMP1 in cardiomyocyte apoptosis was assessed using annexin V-FITC/PI. Echocardiographic assessment, serum creatine kinase MB (CK-MB) and lactate dehydrogenase (LDH), myocardial infarct size, and TUNEL staining were applied in our research. In the MI group, the expression levels of circMACF1 and EMP1 were decreased with the increasing expression level of miR-500b-5p. CircMACF1 upregulated the expression of EMP1 as a sponge of miR-500b-5p, and circMACF1 was a direct target of miR-500b-5p. CircMACF1 impaired the progression of AMI by modulating the miR-500b-5p/EMP1 axis. CircMACF1 may be a potential therapeutic target for treating AMI. Graphical Abstract CircMACF1 upregulated EMP1 expression by sponge miR-500b-5p.

Entities:  

Keywords:  Acute myocardial infarction; Apoptosis; CircMACF1; EMP1; miR-500b-5p

Year:  2020        PMID: 32162171     DOI: 10.1007/s12265-020-09976-5

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  24 in total

Review 1.  Exosomal miRNAs in Heart Disease.

Authors:  Claudio Iaconetti; Sabato Sorrentino; Salvatore De Rosa; Ciro Indolfi
Journal:  Physiology (Bethesda)       Date:  2016-01

2.  ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

Authors:  Ph Gabriel Steg; Stefan K James; Dan Atar; Luigi P Badano; Carina Blömstrom-Lundqvist; Michael A Borger; Carlo Di Mario; Kenneth Dickstein; Gregory Ducrocq; Francisco Fernandez-Aviles; Anthony H Gershlick; Pantaleo Giannuzzi; Sigrun Halvorsen; Kurt Huber; Peter Juni; Adnan Kastrati; Juhani Knuuti; Mattie J Lenzen; Kenneth W Mahaffey; Marco Valgimigli; Arnoud van 't Hof; Petr Widimsky; Doron Zahger
Journal:  Eur Heart J       Date:  2012-08-24       Impact factor: 29.983

3.  circRNA biogenesis competes with pre-mRNA splicing.

Authors:  Reut Ashwal-Fluss; Markus Meyer; Nagarjuna Reddy Pamudurti; Andranik Ivanov; Osnat Bartok; Mor Hanan; Naveh Evantal; Sebastian Memczak; Nikolaus Rajewsky; Sebastian Kadener
Journal:  Mol Cell       Date:  2014-09-18       Impact factor: 17.970

4.  Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage.

Authors:  Yasuhide Kuwabara; Koh Ono; Takahiro Horie; Hitoo Nishi; Kazuya Nagao; Minako Kinoshita; Shin Watanabe; Osamu Baba; Yoji Kojima; Satoshi Shizuta; Masao Imai; Toshihiro Tamura; Toru Kita; Takeshi Kimura
Journal:  Circ Cardiovasc Genet       Date:  2011-06-02

5.  Down-regulation of EMP1 is associated with epithelial hyperplasia and metaplasia in nasal polyps.

Authors:  Xue Min Yu; Chun Wei Li; Ying Ying Li; Jing Liu; Zhi Bin Lin; Tian Ying Li; Li Zhao; Xin Liang Pan; Li Shi; De Yun Wang
Journal:  Histopathology       Date:  2013-08-29       Impact factor: 5.087

6.  CircRNA_000203 enhances the expression of fibrosis-associated genes by derepressing targets of miR-26b-5p, Col1a2 and CTGF, in cardiac fibroblasts.

Authors:  Chun-Mei Tang; Ming Zhang; Lei Huang; Zhi-Qin Hu; Jie-Ning Zhu; Zhen Xiao; Zhuo Zhang; Qiu-Xiong Lin; Xi-Long Zheng; Min -Yang; Shu-Lin Wu; Jian-Ding Cheng; Zhi-Xin Shan
Journal:  Sci Rep       Date:  2017-01-12       Impact factor: 4.379

Review 7.  Circular RNAs in Cardiovascular Disease: An Overview.

Authors:  Ximin Fan; Xinyu Weng; Yifan Zhao; Wei Chen; Tianyi Gan; Dachun Xu
Journal:  Biomed Res Int       Date:  2017-01-22       Impact factor: 3.411

Review 8.  Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data.

Authors:  Michèle Bally; Nandini Dendukuri; Benjamin Rich; Lyne Nadeau; Arja Helin-Salmivaara; Edeltraut Garbe; James M Brophy
Journal:  BMJ       Date:  2017-05-09

Review 9.  Molecular functions and specific roles of circRNAs in the cardiovascular system.

Authors:  Lesca M Holdt; Alexander Kohlmaier; Daniel Teupser
Journal:  Noncoding RNA Res       Date:  2018-05-14

10.  Circular RNA (circRNA) in Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Front Genet       Date:  2013-12-31       Impact factor: 4.599

View more
  15 in total

Review 1.  Insights into circular RNAs: their biogenesis, detection, and emerging role in cardiovascular disease.

Authors:  Zoe Ward; John Pearson; Sebastian Schmeier; Vicky Cameron; Anna Pilbrow
Journal:  RNA Biol       Date:  2021-03-28       Impact factor: 4.652

2.  Circ-SWT1 Ameliorates H2O2-Induced Apoptosis, Oxidative Stress and Endoplasmic Reticulum Stress in Cardiomyocytes via miR-192-5p/SOD2 Axis.

Authors:  Song Chen; Lixiu Sun; Min Hao; Xian Liu
Journal:  Cardiovasc Toxicol       Date:  2022-01-31       Impact factor: 3.231

3.  miR profile in pagetic osteoclasts: from large-scale sequencing to gene expression study.

Authors:  Hoang Dong Nguyen; Martine Bisson; Michelle Scott; Gilles Boire; Luigi Bouchard; Sophie Roux
Journal:  J Mol Med (Berl)       Date:  2021-10-05       Impact factor: 4.599

Review 4.  Circular RNAs in Sudden Cardiac Death Related Diseases: Novel Biomarker for Clinical and Forensic Diagnosis.

Authors:  Meihui Tian; Zhipeng Cao; Hao Pang
Journal:  Molecules       Date:  2021-02-21       Impact factor: 4.411

Review 5.  Targeting Epigenetics and Non-coding RNAs in Myocardial Infarction: From Mechanisms to Therapeutics.

Authors:  Jinhong Chen; Zhichao Liu; Li Ma; Shengwei Gao; Huanjie Fu; Can Wang; Anmin Lu; Baohe Wang; Xufang Gu
Journal:  Front Genet       Date:  2021-12-20       Impact factor: 4.599

6.  CircTRRAP Knockdown Has Cardioprotective Function in Cardiomyocytes via the Signal Regulation of miR-370-3p/PAWR Axis.

Authors:  Yuan Zhang; Zhenggong Li; Jiao Wang; Hao Chen; Rui He; Hongkun Wu
Journal:  Cardiovasc Ther       Date:  2022-02-15       Impact factor: 3.023

7.  CircRbms1 knockdown alleviates hypoxia-induced cardiomyocyte injury via regulating the miR-742-3p/FOXO1 axis.

Authors:  Bo Liu; Kai Guo
Journal:  Cell Mol Biol Lett       Date:  2022-03-26       Impact factor: 5.787

8.  CircZDBF2 up-regulates RNF145 by ceRNA model and recruits CEBPB to accelerate oral squamous cell carcinoma progression via NFκB signaling pathway.

Authors:  Liang Rong; Bo Chen; Ke Liu; Bingyao Liu; Xinyao He; Juan Liu; Junxia Li; Maodian He; Lei Zhu; Ke Liu; Xiaolei Shi; Yi Shuai; Lei Jin
Journal:  J Transl Med       Date:  2022-04-01       Impact factor: 8.440

Review 9.  Circle the Cardiac Remodeling With circRNAs.

Authors:  Tiqun Yang; Tianxin Long; Tailai Du; Yili Chen; Yugang Dong; Zhan-Peng Huang
Journal:  Front Cardiovasc Med       Date:  2021-06-25

Review 10.  Circular RNAs as Competing Endogenous RNAs in Cardiovascular and Cerebrovascular Diseases: Molecular Mechanisms and Clinical Implications.

Authors:  Xue Min; Dong-Liang Liu; Xing-Dong Xiong
Journal:  Front Cardiovasc Med       Date:  2021-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.